Human leukocyte antigen DQ2/8 prevalence in non-celiac patients with gastrointestinal diseases

World Journal of Gastroenterology

Volumn 19, Issue 16, 2013, Pages 2507-2513

  DiGiacomo, Daniel ^a,b   Santonicola, Antonella ^a   Zingone, Fabiana ^a   Troncone, Edoardo ^a   Caria, Maria Cristina ^c   Borgheresi, Patrizia ^d   Parrilli, Gianpaolo ^d   Ciacci, Carolina ^d,e  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Columbia University ^*  (United States)

^c Celiac Center   (Italy)

^d UNIVERSITY HOSPITAL SAN GIOVANNI DI DIO E RUGGI D ARAGONA   (Italy)

^e UNIVERSITY OF SALERNO   (Italy)

Author keywords

Celiac disease; Gastrointestinal and liver disease; Human leukocyte antigen DQ2 8

Indexed keywords

HLA DQ2 ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENTERITIS; FEMALE; FUNCTIONAL DISEASE; GASTROINTESTINAL DISEASE; GENE FREQUENCY; HLA SYSTEM; HUMAN; IRRITABLE COLON; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE;

EID: 84877303593     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i16.2507     Document Type: Article

References (36)

1. Bergseng E, Sidney J, Sette A, Sollid LM. Analysis of thebinding of gluten T-cell epitopes to various human leukocyteantigen class II molecules. Hum Immunol 2008; 69: 94-100. [PMID: 18361933 DOI: 10.1016/j.humimm.2008.01.002]
2. Gebe JA, Swanson E, Kwok WW. HLA class II peptidebindingand autoimmunity. Tissue Antigens 2002; 59: 78-87. [PMID: 12028533]
3. Erlich H, Valdes AM, Noble J, Carlson JA, Varney M, Concannon P, Mychaleckyj JC, Todd JA, Bonella P, Fear AL, Lavant E, Louey A, Moonsamy P. HLA DR-DQ haplotypesand genotypes and type 1 diabetes risk: analysis of the type1 diabetes genetics consortium families. Diabetes 2008; 57:1084-1092. [PMID: 18252895 DOI: 10.2337/db07-1331]
4. Kokaraki G, Daniilidis M, Yiangou M, Arsenakis M, Karyotis N, Tsilipakou M, Fleva A, Gerofotis A, Karadani N, Yovos JG. Major histocompatibility complex class II (DRB1*,DQA1*, and DQB1*) and DRB1*04 subtypes' associationsof Hashimoto's thyroiditis in a Greek population. TissueAntigens 2009; 73: 199-205. [PMID: 19254248 DOI: 10.1111/j.1399-0039.2008.01182.x]
5. Mustalahti K, Catassi C, Reunanen A, Fabiani E, Heier M,McMillan S, Murray L, Metzger MH, Gasparin M, Bravi E,Mäki M. The prevalence of celiac disease in Europe: resultsof a centralized, international mass screening project. AnnMed 2010; 42: 587-595. [PMID: 21070098 DOI: 10.3109/07853890.2010.505931]
6. Tack GJ, Verbeek WH, Schreurs MW, Mulder CJ. The spectrumof celiac disease: epidemiology, clinical aspects andtreatment. Nat Rev Gastroenterol Hepatol 2010; 7: 204-213. [PMID: 20212505 DOI: 10.1038/nrgastro.2010.23]
7. Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, Elitsur Y, Green PH, Guandalini S, Hill ID, Pietzak M, Ventura A, Thorpe M, Kryszak D, Fornaroli F, Wasserman SS, Murray JA, Horvath K. Prevalence of celiac disease inat-risk and not-at-risk groups in the United States: a largemulticenter study. Arch Intern Med 2003; 163: 286-292. [PMID:12578508 DOI: 10.1001/archinte.163.3.286]
8. Megiorni F, Mora B, Bonamico M, Barbato M, Nenna R, Maiella G, Lulli P, Mazzilli MC. HLA-DQ and risk gradientfor celiac disease. Hum Immunol 2009; 70: 55-59. [PMID:19027045 DOI: 10.1016/j.humimm.2008.10.018]
9. Wolters VM, Wijmenga C. Genetic background of celiacdisease and its clinical implications. Am J Gastroenterol 2008;103: 190-195. [PMID: 18184122 DOI: 10.1111/j.1572-0241.2007.01471.x]
10. Karinen H, Kärkkäinen P, Pihlajamäki J, Janatuinen E, Heikkinen M, Julkunen R, Kosma VM, Naukkarinen A, Laakso M. Gene dose effect of the DQB1*0201 allele contributes toseverity of coeliac disease. Scand J Gastroenterol 2006; 41:191-199. [PMID: 16484124 DOI: 10.1080/00365520500206277]
11. El-Salhy M, Lomholt-Beck B, Gundersen D. The prevalenceof celiac disease in patients with irritable bowel syndrome.Mol Med Rep 2011; 4: 403-405. [PMID: 21468583 DOI:10.3892/mmr.2011.466]
12. Casella G, D'Incà R, Oliva L, Daperno M, Saladino V, Zoli G, Annese V, Fries W, Cortellezzi C. Prevalence of celiac diseasein inflammatory bowel diseases: An IG-IBD multicentrestudy. Dig Liver Dis 2010; 42: 175-178. [PMID: 19786375DOI: 10.1016/j.dld.2009.08.005]
13. Leeds JS, Höroldt BS, Sidhu R, Hopper AD, Robinson K,Toulson B, Dixon L, Lobo AJ, McAlindon ME, HurlstoneDP, Sanders DS. Is there an association between coeliac diseaseand inflammatory bowel diseases? A study of relativeprevalence in comparison with population controls. ScandJ Gastroenterol 2007; 42: 1214-1220. [PMID: 17918008 DOI:10.1080/00365520701365112]
14. Lucendo AJ, Arias Á, Pérez-Martínez I, López-Vázquez A, Ontañón-Rodríguez J, González-Castillo S, De Rezende LC, Rodrigo L. Adult patients with eosinophilic esophagitis donot show an increased frequency of the HLA-DQ2/DQ8genotypes predisposing to celiac disease. Dig Dis Sci 2011; 56:1107-1111. [PMID: 20725783 DOI: 10.1007/s10620-010-1383-2]
15. Albayrak A, Ertek M, Tasyaran MA, Pirim I. Role of HLAallele polymorphism in chronic hepatitis B virus infectionand HBV vaccine sensitivity in patients from eastern Turkey. Biochem Genet 2011; 49: 258-269. [PMID: 21188498 DOI:10.1007/s10528-010-9404-6]
16. Vazquez-Roque MI, Camilleri M, Carlson P, McKinzie S, Murray JA, Brantner TL, Burton DD, Zinsmeister AR. HLADQgenotype is associated with accelerated small boweltransit in patients with diarrhea-predominant irritable bowelsyndrome. Eur J Gastroenterol Hepatol 2011; 23: 481-487. [PMID: 21490506 DOI: 10.1097/MEG.0b013e328346a56e]
17. Garrity-Park MM, Loftus EV, Sandborn WJ, Bryant SC, Smyrk TC. MHC Class II alleles in ulcerative colitis-associatedcolorectal cancer. Gut 2009; 58: 1226-1233. [PMID:19251712]
18. Koskela RM, Karttunen TJ, Niemelä SE, Lehtola JK, Ilonen J, Karttunen RA. Human leucocyte antigen and TNFalphapolymorphism association in microscopic colitis. Eur J GastroenterolHepatol 2008; 20: 276-282. [PMID: 18334870 DOI:10.1097/MEG.0b013e3282f2468d]
19. Robinson J, Mistry K, McWilliam H, Lopez R, Parham P,Marsh SG. The IMGT/HLA database. Nucleic Acids Res 2011;39: D1171-D1176. [PMID: 21071412 DOI: 10.1093/nar/gkq998]
20. Buhler S, Sanchez-Mazas A. HLA DNA sequence variationamong human populations: molecular signatures ofdemographic and selective events. PLoS One 2011; 6: e14643. [PMID: 21408106 DOI: 10.1371/journal.pone.0014643]
21. Megiorni F, Mora B, Bonamico M, Barbato M, Montuori M, Viola F, Trabace S, Mazzilli MC. HLA-DQ and susceptibilityto celiac disease: evidence for gender differences and parent-of-origin effects. Am J Gastroenterol 2008; 103: 997-1003. [PMID: 18177450 DOI: 10.1111/j.1572-0241.2007.01716.x]
22. Salamon H, Klitz W, Easteal S, Gao X, Erlich HA, Fernandez-Viña M, Trachtenberg EA, McWeeney SK, Nelson MP, Thomson G. Evolution of HLA class II molecules: Allelicand amino acid site variability across populations. Genetics 1999; 152: 393-400. [PMID: 10224269]
23. Guerini FR, Fusco C, Mazzi B, Favoino B, Nocera G, Agliardi C, Ceresa D, Valentino M, Mininni D, Zanzottera M, Ferrante P, Lombardi ML. HLA-Cw allele frequencies in northernand southern Italy. Transpl Immunol 2008; 18: 286-289. [PMID:18047939 DOI: 10.1016/j.trim.2007.08.003]
24. Bourgey M, Calcagno G, Tinto N, Gennarelli D, Margaritte-Jeannin P, Greco L, Limongelli MG, Esposito O, Marano C, Troncone R, Spampanato A, Clerget-Darpoux F, Sacchetti L. HLA related genetic risk for coeliac disease. Gut 2007; 56:1054-1059. [PMID: 17344279 DOI: 10.1136/gut.2006.108530]
25. Audet M, Piardi T, Cag M, Navarro F, Ornis S, Cinqualbre J, Wolf P, Panaro F. Hepatitis C recurrence after liver transplantation:has the human leukocyte antigen mismatchingat individual loci a role? J Gastroenterol Hepatol 2011; 26:1772-1778. [PMID: 22097939]
26. Boberg KM, Spurkland A, Rocca G, Egeland T, Saarinen S, Mitchell S, Broomé U, Chapman R, Olerup O, Pares A, Rosina F, Schrumpf E. The HLA-DR3,DQ2 heterozygous genotypeis associated with an accelerated progression of primarysclerosing cholangitis. Scand J Gastroenterol 2001; 36: 886-890. [PMID: 11495087 DOI: 10.1111/j.1440-1746.2011.06772.x]
27. Lahner E, Spoletini M, Buzzetti R, Corleto VD, Vannella L, Petrone A, Annibale B. HLA-DRB1*03 and DRB1*04 are associatedwith atrophic gastritis in an Italian population. DigLiver Dis 2010; 42: 854-859. [PMID: 20627832 DOI: 10.1016/j.dld.2010.04.011]
28. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology2006; 130: 1480-1491. [PMID: 16678561 DOI: 10.1053/j.gastro.2005.11.061]
29. Ford AC, Ching E, Moayyedi P. Meta-analysis: yield of diagnostictests for coeliac disease in dyspepsia. Aliment PharmacolTher 2009; 30: 28-36. [PMID: 19416130 DOI: 10.1111/j.1365-2036.2009.04008.x]
30. Puglisi F, Capuano P, Simone M, Verzillo F, Laurentaci C, Catalano G. Immunogenetics of inflammatory bowel disease. Minerva Gastroenterol Dietol 1999; 45: 5-9. [PMID: 16498309]
31. Wahnschaffe U, Schulzke JD, Zeitz M, Ullrich R. Predictorsof clinical response to gluten-free diet in patients diagnosedwith diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol 2007; 5: 844-850; quiz 769. [PMID:17553753 DOI: 10.1016/j.cgh.2007.03.021]
32. Wahnschaffe U, Ullrich R, Riecken EO, Schulzke JD. Celiacdisease-like abnormalities in a subgroup of patientswith irritable bowel syndrome. Gastroenterology 2001; 121:1329-1338. [PMID: 11729112]
33. Sapone A, Bai JC, Ciacci C, Dolinsek J, Green PH, Hadjivassiliou M, Kaukinen K, Rostami K, Sanders DS, Schumann M, Ullrich R, Villalta D, Volta U, Catassi C, Fasano A. Spectrumof gluten-related disorders: consensus on new nomenclatureand classification. BMC Med 2012; 10: 13. [PMID: 22313950DOI: 10.1186/1741-7015-10-13]
34. Megiorni F, Mora B, Bonamico M, Nenna R, Di Pierro M, Catassi C, Drago S, Mazzilli MC. A rapid and sensitivemethod to detect specific human lymphocyte antigen (HLA)class II alleles associated with celiac disease. Clin ChemLab Med 2008; 46: 193-196. [PMID: 18076355 DOI: 10.1515/CCLM.2008.049]
35. Cash BD, Rubenstein JH, Young PE, Gentry A, Nojkov B, Lee D, Andrews AH, Dobhan R, Chey WD. The prevalenceof celiac disease among patients with nonconstipated irritablebowel syndrome is similar to controls. Gastroenterology2011; 141: 1187-1193. [PMID: 21762658 DOI: 10.1053/j.gastro.2011.06.084]
36. Furman DL, Cash BD. The role of diagnostic testing in irritablebowel syndrome. Gastroenterol Clin North Am 2011; 40:105-119. [PMID: 21333903 DOI: 10.1016/j.gtc.2010.12.001]